In Fig. 8a, the strongest predictors were NAFLD/NASH and degree of fibrosis, followed by the other senescence-associated hepatic markers, p21 and p16. Regression also revealed that these predictors were statistically significant. This evidence concerns the gene CDKN2A and metabolic dysfunction-associated steatotic liver disease.